Xeris Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Xeris Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Xeris Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Xeris Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $710k | 316k | 2.25 |
| 2024-03-31 | $556k | 251k | 2.21 |
| 2023-12-31 | $608k | 259k | 2.35 |
| 2023-09-30 | $247k | 133k | 1.86 |
| 2023-06-30 | $587k | 224k | 2.62 |
| 2023-03-31 | $203k | 125k | 1.63 |
| 2022-12-31 | $218k | 164k | 1.33 |
| 2022-06-30 | $173k | 113k | 1.54 |
| 2022-03-31 | $1.9M | 725k | 2.56 |
| 2021-12-31 | $667k | 228k | 2.93 |